Author's posts
Novo Nordisk becomes latest producer to slash insulin prices
Novo Nordisk said it would cut list prices of several of its insulin products by as much as 75 percent, the latest major producer to reduce prices following public pressure to curb the cost of diabetes treatment.
Pfizer seeks another ‘moonshot’ with $43 billion cancer deal
Pfizer said it will buy Seagen, a major push into cancer-fighting drugs as the pharmaceutical giant remakes itself with financial windfall netted from its covid treatments.
Investigation spotlights rise of for-profit ethics boards in research
A federal investigation calls for more oversight of institutional review boards, designed to protect the welfare of people participating in research.
Official end of covid emergency injects uncertainty into telehealth
The federal public health emergency declaration waived the requirement for health-care providers to meet patients in person before prescribing controlled substances.
This doctor prescribes ketamine to thousands online. It’s all legal.
A federal waiver helped give rise to a new industry treating depression with the psychedelic drug ketamine by telemedicine. Now the controversial approach faces an uncertain future.
Alzheimer’s drug shows promise but needs more study for safety, researchers say
The makers of an experimental Alzheimer’s drug showcased its potential as they seek regulatory approval.
- 1
- 2
